Ketamine and esketamine offer rapid relief for treatment-resistant depression, with IV ketamine showing stronger effects and faster onset, while nasal esketamine provides a safer, more convenient option. Both require medical supervision and ongoing maintenance.
24 Jun
FDA Facility Inspections: How the Agency Ensures Quality and Safety
26 Feb
Ketamine and Esketamine: Rapid-Acting Options for Depression
21 Nov
Metformin for PCOS: How It Boosts Ovulation and Insulin Sensitivity
12 Apr
Common FDA Manufacturing Deficiencies and How to Fix Them
18 Nov
Does Loratadine Raise Blood Sugar? What the Research Says